Showing 1 - 10 of 2,806
substitution rule, and the combination of both on generic competition in a Salop-type model with an off-patent brand-name drug and …
Persistent link: https://www.econbiz.de/10010510801
Persistent link: https://www.econbiz.de/10011405945
markets would still lack generic competition …
Persistent link: https://www.econbiz.de/10012852626
Persistent link: https://www.econbiz.de/10010425130
Persistent link: https://www.econbiz.de/10010345456
Persistent link: https://www.econbiz.de/10011498384
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is … the application of biotechnology to drug development as well as firms that specialize in low-cost production of off-patent …
Persistent link: https://www.econbiz.de/10014025576
Persistent link: https://www.econbiz.de/10011660160
The literature on the Indian pharmaceutical industry has examined the importance of product patents and the attempts policy has made to regulate them. However, it has not done the same for the question of brands. Our study addresses this gap. The Tariff Commission Report of 1968, a turning point...
Persistent link: https://www.econbiz.de/10014636929
Persistent link: https://www.econbiz.de/10009578828